(HealthDay)—There has been an unusually high number of cases of thrombotic microangiopathy associated with severe or malignant hypertension in patients with multiple sclerosis who were receiving therapy with recombinant ...
Mar 27, 2014
0
0
Two vaccines to protect against respiratory syncytial virus (RSV) are now available for those over age 60, but a vaccine to protect young children is still in development. "The Long-Awaited RSV Vaccine" provides an update ...
Jul 21, 2023
0
1
A new study, published in the Journal of Experimental Medicine, shows that about 2% of the population develop autoantibodies against type 1 interferons, mostly later in life. This makes individuals more susceptible to viral ...
Jul 17, 2024
0
55
Glucocorticoids are widely used in treating acute respiratory distress syndrome (ARDS) despite there being no indisputable scientific evidence of their effectiveness. The main reason seems to be that there is no effective ...
May 29, 2020
0
0
Research presented at Digestive Disease Week (DDW) explores pharmaceutical advances for treating irritable bowel syndrome with diarrhea (IBS-D) and hepatitis C.
May 20, 2013
0
0
Neurobrucellosis is a severe long-term complication of brucellosis, one of the most common bacterial zoonotic diseases. Scientists have now developed a novel animal model that indicates that innate lymphoid cells and interferons ...
Aug 10, 2023
0
1
New research presented today shows that interferon alpha (IFNa) based therapies are effective in suppressing disease progression in a severe form of chronic viral hepatitis, Hepatitis delta.
Apr 15, 2016
0
0
Toronto)—A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.
Mar 21, 2017
0
0
